Switch from Ibalizumab to Lenacapavir in a Rescue Regimen for a Heavily Treatment-Experienced (HTE) Patient with Multidrug-Resistant (MDR) HIV-1 Infection.

Saved in:
Bibliographic Details
Title: Switch from Ibalizumab to Lenacapavir in a Rescue Regimen for a Heavily Treatment-Experienced (HTE) Patient with Multidrug-Resistant (MDR) HIV-1 Infection.
Authors: Martini, Salvatore1 (AUTHOR) salvatoremartini76@gmail.com, Salmoni, Lorenzo1,2 (AUTHOR), Palladino, Roberta1 (AUTHOR), Russo, Antonio1,2 (AUTHOR), Cuomo, Nunzia2 (AUTHOR), Raddi, Adriana2 (AUTHOR), Starace, Mario1 (AUTHOR), Minichini, Carmine1 (AUTHOR), Pisaturo, Mariantonietta1 (AUTHOR), Coppola, Nicola1 (AUTHOR)
Source: International Journal of Molecular Sciences. Sep2025, Vol. 26 Issue 18, p8881. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16616596
DOI:10.3390/ijms26188881